FDA Clinical Trial Oversight: Agency Must Ensure “System Is Not Broken”
This article was originally published in The Tan Sheet
Executive Summary
FDA needs to demonstrate to the public that the "clinical trial system is not broken," Associate Commissioner Murray Lumpkin, MD, said at the American Association of Pharmaceutical Scientists' recent annual meeting in Toronto